Conference recordings – REVIVE

About
Experts
Webinars & Conferences
Antimicrobial Viewpoints
Resources
JOIN US
My account
- Logout

Loading...

Conferences
WEBINARS

View all our past webinars.

You are here:Home-Conference recordings

Choosing wisely — is your product worth developing? — Choosing wisely — is your product worth developing?
20 April 2021

Antimicrobial Chemotherapy Conference 2021

2 February 2021

Top 10 mistakes in antibacterial development — Top 10 mistakes in antibacterial development
24 August 2020

Bootcamp: Post-Approval Economics for New Antibiotics (ASM/ESCMID 2019) — Bootcamp: Post-Approval Economics for New Antibiotics (ASM/ESCMID 2019)
3 September 2019

Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process (ASM/ESCMID 2019) — Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process (ASM/ESCMID 2019)
3 September 2019

Enabling Academia to Fill the Discovery Gap — Enabling Academia to Fill the Discovery Gap
24 June 2019

New initiatives to support AMR innovation (BSAC Spring Conference 2019) — New initiatives to support AMR innovation (BSAC Spring Conference 2019)
21 March 2019

Resistance testing – beyond serial passage experiments — Resistance testing – beyond serial passage experiments
14 March 2019

Antimicrobial Chemotherapy Conference 2019 — Antimicrobial Chemotherapy Conference 2019
15 January 2019

Bootcamp: Preclinical Toxicology (ESCMID/ASM 2018) — Bootcamp: Preclinical Toxicology (ESCMID/ASM 2018)
4 September 2018

Bootcamp: Medicinal Chemistry (ESCMID/ASM 2018) — Bootcamp: Medicinal Chemistry (ESCMID/ASM 2018)
4 September 2018

Coping with Preclinical Toxicology Challenges — Coping with Preclinical Toxicology Challenges
10 June 2018

1
2
Next »

Share

Facebook Twitter Reddit LinkedIn Email

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. We were created to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.

Content

Antimicrobial Viewpoints (42)
Conferences recordings (19)
Experts (148)
External webinars (19)
Uncategorized (2)
Webinars (46)

Search site

Search for:

CONNECT

Twitter
LinkedIn
YouTube

GARDP
DNDi

© All Rights Reserved

Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy